Entering text into the input field will update the search result below

Translate Bio prices upsized initial public offering

Jun. 27, 2018 6:47 PM ETSanofi (SNY) StockVRTX, NVS, SNY, PLX, GRFS, GLPG, KA, VRNABy: Jason Aycock, SA News Editor
  • Translate Bio (NASDAQ:TBIO) has priced an upsized initial public offering at $13/share, the midpoint of its range.
  • It's selling 9.4M shares, bringing gross raise to $122.2M.
  • It's expected to start trading on Nasdaq Global Market tomorrow.
  • The company lists a number of major competitors in cystic fibrosis therapeutics, including Vertex Pharmaceuticals (NASDAQ:VRTX), Copernicus Therapeutics, Flatley Discovery Lab, Galapagos (NASDAQ:GLPG), Grifols (NASDAQ:GRFS), NovaBiotics, Novartis (NYSE:NVS), Novotersis, Parion Sciences, Proteostasis Therapeutics (NASDAQ:PTI), Protalix BioTherapeutics (NYSEMKT:PLX), Sanofi (NASDAQ:SNY), Spyryx Biosciences, and Verona Pharma (NASDAQ:VRNA).

Recommended For You

More Trending News

About SNY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SNY--
Sanofi